Rock Springs Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
Other funds holding WX
Rock Springs Capital Management's WX Position: Q4 2015 in Review
Rock Springs Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 175,000 shares — an estimated $7.56M sold.
Rock Springs Capital Management first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $7.56M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.
- Rock Springs Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
- Rock Springs Capital Management sold 175,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $7.56M.
- Rock Springs Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
- Rock Springs Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.56M in Q3 2015.
- 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.
Based on Rock Springs Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.